Glaxo’s Injectable Asthma Treatment ‘Nucala’ Gets Approval From FDA – International Business Times

Glaxo's Injectable Asthma Treatment 'Nucala' Gets Approval From FDA
International Business Times
The U.S. Food and Drug Administration (FDA) has given a go ahead to GlaxoSmithKline Plc's drug Nucala for treatment of severe asthma. The regulato6ry body said that the drug can be used in combination with other therapies and medications for asthma …
FDA Approves New Asthma MedicationSMN Weekly (blog)
Mepolizumab gets green signal from FDA to be used for maintenance treatment of …NYC Today
GlaxoSmithKline plc (ADR): Why Nucala's FDA Approval Is SignificantBidness ETC

all 4 news articles »